Cargando…
Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43–45 years
BACKGROUND: Alpha-1-antitrypsin deficiency (AATD) is a hereditary disorder. AATD is a known risk factor for the development of emphysema and liver disease. A cohort of severe (PiZZ) and moderate (PiSZ) AAT-deficient newborn infants was identified by the Swedish national neonatal AAT screening in 197...
Autores principales: | Mostafavi, Behrouz, Piitulainen, Eeva, Tanash, Hanan A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400233/ https://www.ncbi.nlm.nih.gov/pubmed/30880942 http://dx.doi.org/10.2147/COPD.S183205 |
Ejemplares similares
-
Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37–40 years
por: Piitulainen, Eeva, et al.
Publicado: (2017) -
Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age
por: Mostafavi, Behrouz, et al.
Publicado: (2017) -
Acoustic radiation force impulse (ARFI) elastography in a cohort of alpha-1 antitrypsin-deficient individuals and healthy volunteers
por: Diaz, Sandra, et al.
Publicado: (2018) -
Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42
por: Schramm, Georg Rüdiger, et al.
Publicado: (2021) -
Liver disease in adults with severe alpha-1-antitrypsin deficiency
por: Tanash, Hanan A., et al.
Publicado: (2019)